Photo of Ted Cruz
R United States Senate · Texas

Sen. Ted Cruz

Compare
Total votes
1,037
all sessions
Attendance
95%
50 missed
Lower than 90% of chamber peers
With party
92%
of cast votes
Near the chamber average
Bipartisan score
4%
crosses aisle rarely
Near the chamber average
Sponsored
1,349
bills & resolutions
Near the chamber average
Committees
17
assignments
1,349 bills and resolutions

Sponsored bills

Total
1,349
Primary
376
Co-sponsor
973
This page
1,349
matching current filters
Co-sponsor S 251
In committee · Oregon Senate · Co-sponsor
Protection of Women and Girls in Sports Act of 2021

Protection of Women and Girls in Sports Act of 2021 This bill makes it a violation of federal law for a recipient of federal funds who operates, sponsors, or facilitates athletic programs or activities to permit a person whose sex is male to participate in an athletic program or activity that is designated for women or girls. The bill specifies that sex shall be recognized based solely on a person's reproductive biology and genetics at birth.

In committee Feb 4, 2021 1 co-sponsor
Co-sponsor S 229
In committee · Oregon Senate · Co-sponsor
FDIC Act

Financial Defense for Industrial Contractors Act or the FDIC Act This bill requires the Federal Deposit Insurance Corporation to begin proceedings for terminating the insured status of large depository institutions that deny banking services to federal contractors that otherwise qualify for such services.

In committee Feb 4, 2021 1 co-sponsor
Co-sponsor S 241
In committee · Oregon Senate · Co-sponsor
ARTICLE ONE Act

Assuring that Robust, Thorough, and Informed Congressional Leadership is Exercised Over National Emergencies Act or the ARTICLE ONE Act This bill terminates a declaration of national emergency made by the President after 30 days unless Congress votes to extend the declaration. (Currently, Congress can cancel an emergency declaration only by passing a resolution that can withstand a presidential veto.) The bill establishes procedures for congressional review of declarations of national emergencies. The President shall (1) transmit specified information to Congress with any proclamation declaring or renewing a national emergency, including a description of the circumstances necessitating the declaration or renewal of a national emergency declaration and its estimated duration; and (2) report periodically on the status of the emergency.

In committee Feb 4, 2021 1 co-sponsor
Co-sponsor S 239
In committee · Oregon Senate · Co-sponsor
American Values Act

American Values Act This bill expands and makes permanent certain restrictions that prohibit the use of U.S. foreign assistance to pay for the performance or promotion of abortion services overseas. Current law generally prohibits the use of foreign assistance for abortions through language included in appropriations bills. This bill specifically prohibits the use of any funds under the Foreign Assistance Act for (1) abortions or involuntary sterilization as methods of family planning, or (2) biomedical research that relates to these practices as methods of family planning. In addition, the bill makes permanent prohibitions on the use of such funds to (1) lobby for or against abortion, or (2) fund any organization or program that supports or participates in coercive abortion or involuntary sterilization. The bill also makes permanent a prohibition on the use of funds made available to the Peace Corps to pay for abortions.

In committee Feb 4, 2021 1 co-sponsor
Primary S 197
In committee · Oregon Senate · Lead sponsor
CREATE JOBS Act

Cost Recovery and Expensing Acceleration to Transform the Economy and Jumpstart Opportunities for Businesses and Startups Act or the CREATE JOBS Act This bill allows permanent expensing of qualified property (i.e., property with a recovery period of 20 years or less and that is computer software, water utility property, or film, television, or live theatrical production property). It also modifies depreciation provisions for residential rental property and nonresidential real property. The bill repeals provisions for the amortization of research and experimental expenditures, thus providing for direct expensing of such expenditures.

In committee Feb 3, 2021 0 co-sponsors
Primary S 152
In committee · Oregon Senate · Lead sponsor
Right to Test Act

Right to Test Act This bill authorizes a state's public health department, or another entity designated by the state's governor, to approve a diagnostic test or diagnostic device (e.g., a test for the virus that causes COVID-19, or coronavirus disease 2019) for use during a public health emergency. Unless requested by the governor of the state, the Food and Drug Administration (FDA) must not, during the emergency, engage in certain enforcement actions related to such a test or device. Not later than 180 days following the end of the public health emergency, the FDA must review and make a final determination concerning approval of the test or device.

In committee Feb 2, 2021 0 co-sponsors
Co-sponsor S 185
In committee · Oregon Senate · Co-sponsor
Cancel the Coin Act

Cancel the Coin Act This bill prohibits the Department of the Treasury from minting or issuing any coin, including platinum bullion coins and proof platinum coins, having a nominal or face value exceeding $200.

In committee Feb 2, 2021 1 co-sponsor
Primary S 154
In committee · Oregon Senate · Lead sponsor
Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2021

Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2021 This bill establishes a reciprocal marketing approval process that allows for the sale of a drug, biological product, or medical device that has not been approved by the Food and Drug Administration (FDA) if the product is approved for sale in another country and there is an unmet need. Specifically, the bill requires the product's sponsor to demonstrate, among other things, that (1) the product has been approved in one of the specified countries, (2) neither the FDA nor any of the specified countries have withdrawn approval for the product because of safety or effectiveness concerns, and (3) there is a public health or unmet medical need for the product. The FDA may decline approval if the FDA determines that the product is not safe or effective. The FDA may condition reciprocal approval on the conduct of postmarket studies. The FDA must issue a decision on whether to grant a request for reciprocal marketing approval within 30 days of receiving the request. Congress may pass a joint resolution to grant reciprocal marketing approval of a product that the FDA declines to approve through the reciprocal process.

In committee Feb 2, 2021 0 co-sponsors
Showing 1,311 to 1,320 of 1,349 bills